The BIO International Convention 2018 in Boston and the American Society of Clinical Oncology (ASCO) meeting in Chicago, two of the important events in the biotech sector's annual calendar, are almost upon us. With that in mind, BioWorld Asia dives into the business of financial aspects of cancer. There is no doubt that transformative cancer therapies have attracted the attention of everyone, particularly investors, since they first burst on the scene a few years ago.